Novel Prognostic Markers in the Serum of Patients With Castration-Resistant Prostate Cancer Derived From Quantitative Analysis of the Pten Conditional Knockout Mouse Proteome-Reference-Cited by-同舟云学术

Novel Prognostic Markers in the Serum of Patients With Castration-Resistant Prostate Cancer Derived From Quantitative Analysis of the Pten Conditional Knockout Mouse Proteome

Published:2011-12 Issue:6 Volume:60 Page:1235-1243
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Kälin Martin,Cima Igor,Schiess Ralph,Fankhauser Niklaus,Powles Tom,Wild Peter,Templeton Arnoud,Cerny Thomas,Aebersold Ruedi,Krek Wilhelm,Gillessen Silke

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer;Halabi;J Clin Oncol,2003

2. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration;Smaletz;J Clin Oncol,2002

3. A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis;Armstrong;Clin Cancer Res,2007

4. Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era;Bianco;Urol Oncol,2008

5. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial;Beer;Cancer,2008

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis;Journal of Neuro-Oncology;2024-06-05

2. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery;Biomedicines;2023-12-28

3. Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma;Cell Reports Medicine;2023-09

4. Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities—A Systematic Review;Cancers;2023-08-05

5. Proteomics: A modern tool for identifying therapeutic targets in different types of carcinomas;Proteomics;2023